Company · MOBI
Mobia Medical, Inc.
Nasdaq's symbol directory lists MOBI on Nasdaq as “Mobia Medical, Inc. - Common Stock”.
In the 12 months to Nov 8, 2026: insiders bought on 7 occasions ($3.6M); insiders sold on 1 occasion (value not filed); 2 filings by holders of 5% or more; 1 company report (Form 8-K, since May 26, 2026).
Insider trades · SEC Form 4
Those inside the hall
Open-market purchases and sales only. Legs one person filed for one day are combined.
Who traded
- Green Park & Golf Ventures II, LLC bought $1.7M
- Tansey Casey M bought $996K
- Green Park & Golf Ventures - Houston, LLC bought $908K
- Chase C. Leavitt, General Counsel and Corporate Secretary bought $21K
Every trade (8)
- BUYChase C. Leavitt, General Counsel and Corporate Secretary bought $21K
- BUYTansey Casey M bought $199K
- BUYTansey Casey M bought $203K
- BUYTansey Casey M bought $184K
- BUYTansey Casey M bought $409K
- BUYGreen Park & Golf Ventures II, LLC bought $1.7M
- BUYGreen Park & Golf Ventures - Houston, LLC bought $908K
- SELLGreen Park & Golf Ventures II, LLC sold —
Large holders · SEC Schedules 13D and 13G
Five percent and over
Anyone who comes to hold more than 5% of a company's voting shares must tell the SEC. A Schedule 13D is filed by a holder who may seek to influence the company; a 13G by one who states it is a passive investor. An amendment updates an earlier filing, and a stake reported as 0% means the holder says it has sold all, or nearly all, of its shares. Every recent 13D and 13G
- GPG BFH, LLC 11.1%
- U.S. Venture Partners XII, L.P. 11.6%
Company reports · SEC Form 8-K
In its own words
Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.
- Results of operations and financial condition Nov 5, 2026
Sources: SEC EDGAR (Forms 4, 144 and 8-K) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.